{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,13]],"date-time":"2025-04-13T00:35:22Z","timestamp":1744504522178,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteonecrosis is a major cause of morbidity for patients with systemic lupus erythematosus (SLE). Although core decompression is an approved and trusted technique to prevent further joint deterioration, this surgical method seems to be less beneficial for SLE patients. We aimed to evaluate the outcomes of core decompression in SLE patients with primary stages of femoral head osteonecrosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, 23 patients (39 affected hip joints) with osteonecrosis of the femoral head with stage II of the disease, based on the Ficat-Arlet classification system, underwent core decompression. Also, patients demographic characteristics, clinical data, medication history, comorbidities, immunological findings, hip plain radiographs, history of total hip arthroplasty after core decompression, and patients satisfaction with joint function according to the Oxford hip score questionnaire were obtained.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the study, 53.8% of affected joints showed signs of radiographic deterioration in follow-up imaging. Sixty-one and a half percent (61.5%) of patients had unsatisfactory joint performance. A\u00a0third (33.3%) of affected hip joints underwent total hip arthroplasty up to 5 years from core decompression. SLE patients with a history of receiving bisphosphonate were 83.2% less dissatisfied with their joint function than patients without a history of bisphosphonate use (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.02). Of the 23 studied cases, the mean cumulative dose of prednisolone before and after core decompression surgery was 46.41 mg and 14.74 mg respectively. Besides, one case (2.6%) that had a high anti-phospholipid antibodies level during follow-up did not have any radiographic deterioration, and 9 cases (23.1%) had some degrees of radiographic deterioration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The patients group that used bis-phosphonate, had a higher level of satisfaction with joint function after core decompression. Patients with high-level anti-phospholipid antibodies are related to a poor prognosis after core decompression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s42358-023-00345-9","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:02:41Z","timestamp":1704200561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of core decompression outcome in systemic lupus erythematosus with hip osteonecrosis: a retrospective cohort study"],"prefix":"10.1186","volume":"64","author":[{"given":"Pouya","family":"Hadighi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedeh Tahereh","family":"Faezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad Javad","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-4251","authenticated-orcid":false,"given":"Mohsen","family":"Rokni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Aghaghazvini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Kasaeian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Nejadhosseinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Haerian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Fateh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"345_CR1","doi-asserted-by":"publisher","first-page":"1151246","DOI":"10.3389\/fimmu.2023.1151246","volume":"14","author":"M Sadeghi Shaker","year":"2023","unstructured":"Sadeghi Shaker M, Rokni M, Mahmoudi M, Farhadi E. Ras family signaling pathway in immunopathogenesis of inflammatory rheumatic diseases. Front Immunol. 2023;14:1151246.","journal-title":"Front Immunol"},{"issue":"5","key":"345_CR2","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/1756-185X.13808","volume":"23","author":"M Sandoughi","year":"2020","unstructured":"Sandoughi M, Saravani M, Rokni M, Nora M, Mehrabani M, Dehghan A. Association between COX-2 and 15-PGDH polymorphisms and SLE susceptibility. Int J Rheum Dis. 2020;23(5):627\u201332.","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"345_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1756-185X.2010.01547.x","volume":"13","author":"M Akbarian","year":"2010","unstructured":"Akbarian M, Faezi ST, Gharibdoost F, Shahram F, Nadji A, Jamshidi AR, et al. Systemic lupus erythematosus in Iran: a study of 2280 patients over 33 years. Int J Rheum Dis. 2010;13(4):374\u20139.","journal-title":"Int J Rheum Dis"},{"issue":"12","key":"345_CR4","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.12998\/wjcc.v8.i12.2530","volume":"8","author":"HS Sun","year":"2020","unstructured":"Sun HS, Yang QR, Bai YY, Hu NW, Liu DX, Qin CY. Gene testing for osteonecrosis of the femoral head in systemic lupus erythematosus using targeted next-generation sequencing: a pilot study. World J Clin Cases. 2020;8(12):2530\u201341.","journal-title":"World J Clin Cases"},{"issue":"12","key":"345_CR5","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2106\/JBJS.19.01271","volume":"102","author":"MA Mont","year":"2020","unstructured":"Mont MA, Salem HS, Piuzzi NS, Goodman SB, Jones LC. Nontraumatic osteonecrosis of the femoral head: where do we stand today?: a 5-year update. J Bone Joint Surg Am. 2020;102(12):1084\u201399.","journal-title":"J Bone Joint Surg Am"},{"key":"345_CR6","doi-asserted-by":"crossref","unstructured":"Lespasio MJ, Sodhi N, Mont MA. Osteonecrosis of the hip: a primer. Permanente J. 2019;23","DOI":"10.7812\/TPP\/18-100"},{"key":"345_CR7","first-page":"179","volume":"56","author":"LC Jones","year":"2007","unstructured":"Jones LC, Hungerford DS. The pathogenesis of osteonecrosis. Instr Course Lect. 2007;56:179\u201396.","journal-title":"Instr Course Lect"},{"key":"345_CR8","doi-asserted-by":"crossref","unstructured":"Chen S, Cai Q, Xu Y, Fu Q, Feng Y, Chen X, et al. Associations between glucocorticoids, antiphospholipid antibodies and femur head necrosis in patients with SLE: a directed acyclic graph-based multicentre study. Therapeutic advances in musculoskeletal disease. 2021;13:1759720X211002677.","DOI":"10.1177\/1759720X211002677"},{"key":"345_CR9","doi-asserted-by":"crossref","unstructured":"Mont MA, Pivec R, Banerjee S, Issa K, Elmallah RK, Jones LC. High-dose corticosteroid use and risk of hip osteonecrosis: meta-analysis and systematic literature review. J Arthroplast. 2015;30(9):1506\u201312 e5.","DOI":"10.1016\/j.arth.2015.03.036"},{"issue":"10","key":"345_CR10","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3899\/jrheum.170837","volume":"45","author":"S Hussein","year":"2018","unstructured":"Hussein S, Suitner M, B\u00e9land-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, et al. Monitoring of osteonecrosis in systemic lupus erythematosus: a systematic review and metaanalysis. J Rheumatol. 2018;45(10):1462\u201376.","journal-title":"J Rheumatol"},{"issue":"4","key":"345_CR11","doi-asserted-by":"publisher","first-page":"590","DOI":"10.3109\/14397595.2014.987366","volume":"25","author":"ST Faezi","year":"2015","unstructured":"Faezi ST, Hoseinian AS, Paragomi P, Akbarian M, Esfahanian F, Gharibdoost F, et al. Non-corticosteroid risk factors of symptomatic avascular necrosis of bone in systemic lupus erythematosus: a retrospective case-control study. Mod Rheumatol. 2015;25(4):590\u20134.","journal-title":"Mod Rheumatol"},{"issue":"5\u20136","key":"345_CR12","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s004020050456","volume":"120","author":"S Maniwa","year":"2000","unstructured":"Maniwa S, Nishikori T, Furukawa S, Kajitani K, Iwata A, Nishikawa U, et al. Evaluation of core decompression for early osteonecrosis of the femoral head. Arch Orthop Trauma Surg. 2000;120(5\u20136):241\u20134.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"5","key":"345_CR13","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11999-008-0184-9","volume":"466","author":"DR Marker","year":"2008","unstructured":"Marker DR, Seyler TM, Ulrich SD, Srivastava S, Mont MA. Do modern techniques improve core decompression outcomes for hip osteonecrosis? Clin Orthop Relat Res. 2008;466(5):1093\u2013103.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"345_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12178-015-9279-6","volume":"8","author":"TP Pierce","year":"2015","unstructured":"Pierce TP, Jauregui JJ, Cherian JJ, Elmallah RK, Mont MA. Imaging evaluation of patients with osteonecrosis of the femoral head. Curr Rev Musculoskelet Med. 2015;8(3):221\u20137.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"12","key":"345_CR15","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1136\/ard.60.12.1145","volume":"60","author":"K Oinuma","year":"2001","unstructured":"Oinuma K, Harada Y, Nawata Y, Takabayashi K, Abe I, Kamikawa K, et al. Osteonecrosis in patients with systemic lupus erythematosus develops very early after starting high dose corticosteroid treatment. Ann Rheum Dis. 2001;60(12):1145\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"345_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/bmb\/ldw010","volume":"118","author":"F Sadile","year":"2016","unstructured":"Sadile F, Bernasconi A, Russo S, Maffulli N. Core decompression versus other joint preserving treatments for osteonecrosis of the femoral head: a meta-analysis. Br Med Bull. 2016;118(1):33\u201349.","journal-title":"Br Med Bull"},{"issue":"1","key":"345_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1302\/0301-620X.67B1.3155745","volume":"67","author":"R Ficat","year":"1985","unstructured":"Ficat R. Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment. J Bone Joint Surgery Br. 1985;67(1):3\u20139.","journal-title":"J Bone Joint Surgery Br"},{"key":"345_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-3-66","volume":"3","author":"V Wylde","year":"2005","unstructured":"Wylde V, Learmonth ID, Cavendish VJ. The Oxford hip score: the patient\u2019s perspective. Health Qual Life Outcomes. 2005;3:1\u20138.","journal-title":"Health Qual Life Outcomes"},{"issue":"9","key":"345_CR19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.reuma.2021.08.004","volume":"18","author":"M Est\u00e9vez Del Toro","year":"2022","unstructured":"Est\u00e9vez Del Toro M, Varela Ceballos I, Chico Capote A, Kokuina E, S\u00e1nchez Bruz\u00f3n Y, Casas FN. Predictive factors for the development of lupus nephritis after diagnosis of systemic lupus erythematosus. Reumatologia Clinica. 2022;18(9):513\u20137.","journal-title":"Reumatologia Clinica"},{"key":"345_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/00003086-199701000-00012","volume":"334","author":"MA Mont","year":"1997","unstructured":"Mont MA, Fairbank AC, Petri M, Hungerford DS. Core decompression for osteonecrosis of the femoral head in systemic lupus erythematosus. Clin Orthop Relat Res. 1997;334:91\u20137.","journal-title":"Clin Orthop Relat Res"},{"issue":"3","key":"345_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248845","volume":"16","author":"SS Shaharir","year":"2021","unstructured":"Shaharir SS, Chua SH, Mohd R, Mustafar R, Noh MM, Shahril NS, et al. Risk factors for symptomatic Avascular Necrosis (AVN) in a multi-ethnic Systemic Lupus Erythematosus (SLE) cohort. PLoS ONE. 2021;16(3): e0248845.","journal-title":"PLoS ONE"},{"issue":"4","key":"345_CR22","first-page":"700","volume":"35","author":"T Nevskaya","year":"2017","unstructured":"Nevskaya T, Gamble MP, Pope JE. A meta-analysis of avascular necrosis in systemic lupus erythematosus: prevalence and risk factors. Clin Experim Rheumatol. 2017;35(4):700\u201310.","journal-title":"Clin Experim Rheumatol"},{"issue":"1","key":"345_CR23","first-page":"29","volume":"17","author":"J Al Saleh","year":"2010","unstructured":"Al Saleh J, El Sayed M, Salah N, Harb D, Khan N, Mohammed N. Predictors of avascular necrosis of the hip in Emiratis patients with systemic lupus erythematosus. Egypt J Immunol. 2010;17(1):29\u201340.","journal-title":"Egypt J Immunol"},{"issue":"11","key":"345_CR24","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.1002\/art.27679","volume":"62","author":"S Duran-Barragan","year":"2010","unstructured":"Duran-Barragan S, Sandoval-Garcia L, Navarrete-Lorenzon M. Additive risk factors resulting in severe osteonecrosis in systemic lupus erythematosus. Arthritis Rheum. 2010;62(11):3276.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"345_CR25","first-page":"654","volume":"24","author":"MA Mont","year":"1997","unstructured":"Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997;24(4):654\u201362.","journal-title":"J Rheumatol"},{"issue":"7","key":"345_CR26","first-page":"10133","volume":"10","author":"J Yin","year":"2017","unstructured":"Yin J, Weng S, Chen Y, Zhang W, Gao Y. Alendronate prevents glucocorticoid-induced osteonecrosis of the femoral head in rats. Int J Clin Exp Med. 2017;10(7):10133\u201342.","journal-title":"Int J Clin Exp Med"},{"issue":"3","key":"345_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.transproceed.2011.02.072","volume":"43","author":"S Paydas","year":"2011","unstructured":"Paydas S, Balal M, Demir E, Sertdemir Y, Erken U. Avascular osteonecrosis and accompanying anemia, leucocytosis, and decreased bone mineral density in renal transplant recipients. Transpl Proc. 2011;43(3):863\u20136.","journal-title":"Transpl Proc"},{"key":"345_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2174\/1874325001206010449","volume":"6","author":"KL Chan","year":"2012","unstructured":"Chan KL, Mok CC. Glucocorticoid-induced avascular bone necrosis: diagnosis and management. Open Orthop J. 2012;6:449\u201357.","journal-title":"Open Orthop J"},{"issue":"8538","key":"345_CR29","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","volume":"1","author":"DT Felson","year":"1987","unstructured":"Felson DT, Anderson JJ. Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone. Lancet (London, England). 1987;1(8538):902\u20136.","journal-title":"Lancet (London, England)"},{"issue":"11","key":"345_CR30","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1093\/rheumatology\/ker277","volume":"50","author":"T Shigemura","year":"2011","unstructured":"Shigemura T, Nakamura J, Kishida S, Harada Y, Ohtori S, Kamikawa K, et al. Incidence of osteonecrosis associated with corticosteroid therapy among different underlying diseases: prospective MRI study. Rheumatology (Oxford). 2011;50(11):2023\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"13","key":"345_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12969-015-0008-x","volume":"23","author":"R Gurion","year":"2015","unstructured":"Gurion R, Tangpricha V, Yow E, Schanberg LE, McComsey GA, Robinson AB. Avascular necrosis in pediatric systemic lupus erythematosus: a brief report and review of the literature. Pediatr Rheumatol Online J. 2015;23(13):13.","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Advances in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-023-00345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42358-023-00345-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42358-023-00345-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T13:02:48Z","timestamp":1704200568000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancesinrheumatology.biomedcentral.com\/articles\/10.1186\/s42358-023-00345-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["345"],"URL":"https:\/\/doi.org\/10.1186\/s42358-023-00345-9","relation":{},"ISSN":["2523-3106"],"issn-type":[{"type":"electronic","value":"2523-3106"}],"subject":[],"published":{"date-parts":[[2024,1,2]]},"assertion":[{"value":"4 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the ethics committee of Tehran university of medical sciences ( IR.TUMS.MEDICINE.REC.1398.723), and written consent was taken from all subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"No conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}